Refuge Biotechnologies Inc.
1505 ADAMS DRIVE, SUITE D
2 articles with Refuge Biotechnologies Inc.
Former President and COO of Celgene to Help Guide Pipeline and Corporate Development Activities.
Chinese investment firms 3SBio and Sequoia China joined a team of other investors to bankroll California-based Refuge Biotechnologies, Inc.’s $25 million funding round to support its gene therapy treatments using CRISPR technology.